S
SAREPTA THERAPEUTICS INC
NASDAQ: SRPT (Sarepta Therapeutics, Inc.)
最近更新时间: 昨天, 8:41PM37.60
-1.01 (-2.62%)
| 前收盘价格 | 38.61 |
| 收盘价格 | 38.05 |
| 成交量 | 2,961,148 |
| 平均成交量 (3个月) | 3,579,562 |
| 市值 | 3,794,479,104 |
| 预期市盈率 (P/E Forward) | 8.34 |
| 价格/销量 (P/S) | 1.84 |
| 股市价格/股市净资产 (P/B) | 3.26 |
| 52周波幅 | |
| 利润日期 | 5 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | 12.37% |
| 营业利益率 (TTM) | 24.56% |
| 稀释每股收益 (EPS TTM) | 2.34 |
| 季度收入增长率 (YOY) | 65.90% |
| 季度盈利增长率 (YOY) | 248.40% |
| 总债务/股东权益 (D/E MRQ) | 87.90% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | -205.79 M |
| 杠杆自由现金流 (LFCF TTM) | -445.48 M |
| 资产报酬率 (ROA TTM) | 3.77% |
| 股东权益报酬率 (ROE TTM) | 19.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Sarepta Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
1.4
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 1.38 |
|
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 4.41% |
| 机构持股比例 | 88.92% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 125.00 (Needham, 232.45%) | 购买 |
| 中 | 98.00 (160.64%) | |
| 低 | 40.00 (HC Wainwright & Co., 6.38%) | 保留 |
| 平均值 | 90.08 (139.57%) | |
| 总计 | 9 购买, 4 保留 | |
| 平均价格@调整类型 | 43.27 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 22 May 2025 | 40.00 (6.38%) | 保留 | 38.79 |
| 07 May 2025 | 40.00 (6.38%) | 保留 | 36.72 | |
| JP Morgan | 20 May 2025 | 84.00 (123.40%) | 购买 | 39.99 |
| Wells Fargo | 08 May 2025 | 100.00 (165.96%) | 购买 | 36.52 |
| 11 Apr 2025 | 115.00 (205.85%) | 购买 | 51.03 | |
| Cantor Fitzgerald | 07 May 2025 | 81.00 (115.43%) | 购买 | 36.72 |
| 19 Mar 2025 | 163.00 (333.51%) | 购买 | 79.97 | |
| Goldman Sachs | 07 May 2025 | 100.00 (165.96%) | 购买 | 36.72 |
| Guggenheim | 07 May 2025 | 98.00 (160.64%) | 购买 | 36.72 |
| Morgan Stanley | 07 May 2025 | 113.00 (200.53%) | 购买 | 36.72 |
| 11 Apr 2025 | 182.00 (384.04%) | 购买 | 51.03 | |
| Needham | 07 May 2025 | 125.00 (232.45%) | 购买 | 36.72 |
| 03 Apr 2025 | 183.00 (386.70%) | 购买 | 58.61 | |
| Oppenheimer | 07 May 2025 | 123.00 (227.13%) | 购买 | 36.72 |
| Piper Sandler | 07 May 2025 | 70.00 (86.17%) | 购买 | 36.72 |
| 21 Apr 2025 | 110.00 (192.55%) | 购买 | 55.23 | |
| RBC Capital | 07 May 2025 | 58.00 (54.26%) | 保留 | 36.72 |
| 31 Mar 2025 | 87.00 (131.38%) | 保留 | 63.82 | |
| Scotiabank | 20 Mar 2025 | 80.00 (112.77%) | 保留 | 73.45 |
| 07 Mar 2025 | 105.00 (179.26%) | 保留 | 103.03 | |
| Deutsche Bank | 19 Mar 2025 | 99.00 (163.30%) | 保留 | 79.97 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合